Functional state of the Hsp27 chaperone as a molecular marker of an unfavorable course of larynx cancer

Abstract

BACKGROUND:

The small heat shock protein 27 kDA (Hsp27) acts as an ATP-independent chaperone in protein folding, but is also implicated in architecture of the cytoskeleton, cell migration, metabolism, cell survival, growth/differentiation, mRNA stabilization, and tumor progression.

OBJECTIVE:

To study the intracellular localization of phosphorylated and non-phosphorylated forms of Hsp27 in squamous cell carcinoma of the larynx (SCCL) and to evaluate their relationship with regional lymphatic metastasis and overall five-year survival.

METHODS:

Tumor biopsies of larynx tissue were collected from 50 patients who were between the ages of 30 to 80 years and had a confirmed diagnosis of squamous cell carcinoma of the larynx. Immunohistochemistry was used to determine the intracellular localization of the phosphorylated and non-phosphorylated forms of Hsp27.

RESULTS:

The study revealed that the Hsp27 chaperone was expressed in both the cytoplasm and the nucleus of tumor cells in SCCL. The biopsies of patients with lymph node metastases showed significantly higher expression of the phosphorylated and unphosphorylated forms of Hsp27 in the nucleus compared to those of patients without lymph node metastases. At the same time, the cytoplasmic expression of Hsp27 in these patients did not differ statistically. Analysis of the overall five-year survival rates showed that negative Hsp27 expression in the nucleus of tumor cells is associated with the survival rate of patients with SCCL.

CONCLUSION:

The nuclear expression of phosphorylated and unphosphorylated forms of Hsp27 is a molecular marker of unfavorable squamous cell carcinoma of the larynx associated with lymphogenous metastasis and decreased total five-year survival.

Keywords

Larynx cancer heat shock protein 27 phospho S78-Hsp27 prognostic markers immunohistochemistry

References

Arrigo

A.P.

, Gibert

, HspB1, HspB5 and HspB4 in human cancers: potent oncogenic role of some of their client proteins. Cancers 6 (2014) 333-365.

Arrigo

A.P.

, Human small heat shock proteins: protein interactomes of homo- and hetero-oligomeric complexes: an update. FEBS Lett 587 (2013) 1959-1969.

Parcellier

, Schmitt

, Gurbuxani

, et al. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 23 (2003) 5790-5802.

Thonel

, Vandekerckhove

, Lanneau

, et al. HSP27 controls GATA-1 protein level during erythroid cell differentiation. Blood 116 (2010) 85-96.

Gibert

, Eckel

, Gonin

, et al. Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo . Br J Cancer 107 (2012) 63-70.

Piura

, Rabinovich

, Yavelsky

, Wolfson

, Heat shock proteins and malignancies of the female genital tract. Harefuah 141 (2002) 962-972.

Cosentino

, Grieco

, Costanzo

, ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30 (2011) 546-555.

Paul

, Manero

, Gonin

, et al. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol 22 (2002) 816-834.

Ciocca

D.R.

, Luque

E.H.

, Immunological evidence for the identity between the Hsp27 estrogen-regulated Heat-Shock Protein and the P29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res Treat 20 (1991) 33-42.

10.

Malusecka

, Krzyzowska-Gruca

, Gawrychowski

, et al. Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma. Anticancer Res 28 (2008) 501-506.

11.

Kaigorodova

E.V.

, Litvinova

L.S.

, Konovalova

E.V.

, et al. The inhibition of Hsp27 chaperone affects the level of p53 protein in tumor cells. Int J Biol 5 (2013) 13-18.

12.

Kaigorodova

E.V.

, Bogatyuk

M.V.

, Heat Shock Proteins as Prognostic Markers of Cancer. Current Cancer Drug Targets 8 (2014) 713-726.

13.

Kaigorodova

E.V.

, Zavyalova

M.V.

, Bogatyuk

M.V.

, Tarabanovskaya

N.A.

, Slonimskaya

E.M.

, Perelmuter

V.M.

, Relationship between the expression of phosphorylated heat shock protein beta-1 with lymph node metastases of breast cancer. Cancer Biomark 2 (2015) 143-150.

14.

Kaigorodova

E.V.

, Ryazantseva

N.V.

, Novitskii

V.V.

, Maroshkina

A.N.

, Belkina

M.V.

, Effects of Hsp27 chaperone on THP-1 tumor cell apoptosis. Bulletin of Experimental Biology and Medicine 1 (2012) 77-79.

15.

Kaigorodova

E.V.

, Novitskiy

V.V.

, Bogatyuk

M.V.

, Inhibition of Hsp27 chaperone increases apoptotic effect of etoposide in tumor cells. International Journal of Cancer Research 47 (2013) 1144-1148.

16.

Storm

F.K.

, Mahvi

D.M.

, Gilchrist

K.W.

, Hsp27 has no diagnostic or prognostic signi?cance in prostate or bladder cancers. Urology 42 (1993) 379-382.

17.

Wettstein

, Bellaye

P.S.

, Micheau

, Bonniaud

, Small heat shock proteins and the cytoskeleton: An essential interplay for cell integrity? Int J Biochem Cell Biol. 44 (2012) 1680-1686.

18.

Bonkhoff

, Fixemer

, Hunsicker

, Remberger

, Estrogen receptor gene expression and its relation to the estrogen-inducible HSP27 heat shock protein in hormone refractory prostate cancer. Prostate 45 (2000) 36-41.

19.

Mese

, Sasaki

, Nakayama

, et al. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma. Oncol Rep 2 (2002) 341-344.

20.

Uozaki

, Ishida

, Kakiuchi

, et al. Expression of heat shock proteins in osteosarcoma and its relationship to prognosis. Pathol Res Pract 196 (2000) 665-673.

21.

King

K.L.

, Li

A.F.

, Chau

G.Y.

, et al. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 88 (2000) 2464-2470.

22.

Lo Muzio

, Leonardi

, Mariggiò

M.A.

, et al. HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma. Histol Histopathol 1 (2004) 119-128.

23.

Vargas-Roig

L.M.

, Gago

F.E.

, Tello

, et al. Heat shock expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 79 (1998) 468-475.

24.

Muzio

, Campisi

, Farina

, et al. Prognostic value of HSP27 in head and neck squamous cell carcinoma: A retrospective analysis of 57 tumours. Anticancer Res 26 (2006) 1343-1349.

25.

Wei

, Liu

T.T.

, Wang

H.H.

, et al. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kB. Breast Cancer Res 13 (2011) R101.

26.

M.L.

, Defren

, Brewer

, Hsp27 and F-Box protein-TrCP promote degradation of mRNA decay factor AUF1. Mol Cell Biol 33 (2013) 2315-2326.

27.

Malumbres

, Barbacid

, To cycle or not to cycle: A critical decision in cancer. Nat Rev Cancer 1 (2001) 222-231.

28.

Nakajima

, Kuwano

, Miyazaki

, Masuda

, Kato

, Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Lett 178 (2002) 99-106.

29.

Shiota

, Bishop

J.L.

, Nip

K.M.

, et al. Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer. Cancer Res 73 (2013) 3109-3119.

30.

Erkizan

, Kirkali

, Yorukoglu

, Kirkali

, Significance of heat shock protein-27 expression in patients with renal cell carcinoma. Urology 64 (2004) 474-478.

31.

Straume

, Shimamura

, Lampa

M.J.

, et al. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc Natl Acad Sci 109 (2012) 8699-8704.

32.

Cornford

P.A.

, Dodson

A.R.

, Parsons

K.F.

, et al. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 60 (2000) 7099-7105.

33.

Pandey

, Farber

, Nakazawa

, et al. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 19 (2000) 1975-1981.

34.

Gandour-Edwards

, Trock

B.J.

, Gumerlock

, Donald

P.J.

, Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 118 (1998) 610-615.

35.

Charette

S.J.

, Lavoie

J.N.

, Lambert

, Landry

, Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol 20 (2000) 7602-7612.

36.

Simon

, Dimitrova

, Gibert

, et al. Analysis of the dominant effects mediated by wild type or R120G mutant of alphaB-crystallin (HspB5) towards Hsp27 (HspB1). PLoS One 8 (2013) e70545.

37.

Takeno

, Noguchi

, Kikuchi

, et al. Analysis of the survival period in respectable stage IV gastric cancer. Ann Surg Oncol 8 (2001) 215-221.

38.

Ito

, Kawabe

, Kurasono

, et al. Expression of heat shock proteins in squamous cell carcinoma of the tongue: An immunohistochemical study. J. Oral Pathol. Med 27 (1998) 18-22.

39.

Preville

, Salvemini

, Giruud

, et al. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exptl Cell Res 247 (1999) 61-78.

40.

Thomas

, Campos

, Mounier

, et al. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res 29 (2005) 1049-1058.

41.

, Zhi

, Peng

, Zhong

, Xu

, Clinical significance of HSP27 expression in colorectal cancer. Mol Med Rep 3 (2010) 953-958.